A clinical review explores symptom-based treatment options for functional dyspepsia and gastroparesis, indicating the need for specialized trials.
Neuromodulators provide a rational, mechanism-based treatment option for FD and GP, and a symptom-oriented approach may optimize patient outcomes; although high-quality, subtype-specific trials are needed to strengthen the evidence base.
No takes yet. Share an insight, caveat, or question.
Hanna-Jairala et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: